Chromatography tells you how homogeneous a sample is. Mass spectrometry tells you what the dominant species weighs. Neither answers the other’s question, and a supplier’s documentation is stronger when it reports both separately rather than blending them into one figure.
What the measurement is
For peptides, electrospray ionisation is standard. The sample is sprayed from solution, molecules acquire one or more protons, and the instrument measures mass-to-charge ratio. Peptides commonly appear in several charge states at once, so a spectrum shows a family of peaks that deconvolute to a single molecular mass. MALDI is also used, typically producing predominantly singly-charged ions and a simpler spectrum.
The measured mass is then compared against the mass calculated from the intended sequence. Two flavours of that calculation exist and confusing them causes avoidable arguments. Monoisotopic mass uses the most abundant isotope of each element; average mass uses natural isotopic abundances. For a small peptide the difference is under a dalton. For a 30-residue peptide it is a few daltons — large enough to look like a discrepancy if you compare a monoisotopic measurement against an average calculation.
What a matching mass establishes
It establishes that the dominant species has the elemental composition expected of the intended sequence. That is meaningful evidence and it is the reason a mass confirmation belongs alongside a purity trace.
What it does not establish
Sequence order. Mass is a sum. Any rearrangement of the same residues gives the same mass. Two peptides with identical composition and different order are indistinguishable by intact mass alone; establishing order requires tandem MS, where the peptide is fragmented and the fragment masses are read as a ladder.
Stereochemistry. A D-amino acid weighs exactly what its L counterpart weighs. Diastereomers arising from racemisation during synthesis are invisible to a mass measurement and can only be caught chromatographically.
Purity. Ionisation efficiency varies substantially between species, so relative peak intensities in a mass spectrum are not proportional to relative abundance in the sample. A minor component that ionises well can dominate a spectrum. Quantitative purity is a chromatography question, not a mass spectrometry one.
Reading a reported mass sensibly
Check that observed and calculated masses are being compared on the same basis, monoisotopic to monoisotopic or average to average. Check whether the reported value came from a deconvoluted spectrum or a raw charge state. And treat a mass that matches to four decimal places on an instrument with unit resolution as a transcription of the calculation rather than a measurement.
Why we do not claim it where we cannot
What we publish is an independent reverse-phase HPLC analysis for each product in the catalogue. Where a supplier claims mass confirmation, ask which instrument, which ionisation mode, and whether the comparison is monoisotopic or average — a supplier who can answer has done the work, and one who cannot has repeated a phrase. We would rather state exactly what our published analysis covers than describe an analysis we do not hold.
For independent identity references, the compound identity links on our product pages point to public chemical databases, where the sequence, formula and calculated masses can be checked against a source with no commercial interest in the answer.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.